Sarasin & Partners »

Monte Rosa Therapeutics shares owned by Sarasin & Partners

Quarter-by-quarter ownership of Monte Rosa Therapeutics (GLUE) shares owned by Sarasin & Partners from 13F filings

Historical chart of Sarasin & Partners investment in Monte Rosa Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Monte Rosa Therapeutics held by Sarasin & Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Monte Rosa Therapeutics by Sarasin & Partners

Quarter filed Position value Share count Share price at filing
2024-03-31 $459k 65k 7.05
2023-12-31 $368k 65k 5.65
2023-09-30 $312k 65k 4.79
2023-06-30 $446k 65k 6.85
2023-03-31 $507k 65k 7.79
2022-12-31 $495k 65k 7.61
2022-09-30 $532k 65k 8.17
2022-06-30 $629k 65k 9.66